Stephen M. Ansell, MD, PhD
Professor, of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota
Mayo Clinic College of Medicine
Rochester, Minnesota
Last modified: November 26, 2018
Authored Items
What are today’s key issues and challenges in the management of front-line classical Hodgkin lymphoma?
FAQ published on December 8, 2017
Beyond current treatment options in frontline therapy, what future changes may lie ahead?
FAQ published on September 29, 2017
How does the safety and efficacy differ between the anti-PD-1 antibodies pembrolizumab & nivolumab?
FAQ published on July 24, 2017
What is the role of new and emerging checkpoint inhibitors in the treatment of classical HL?
FAQ published on June 19, 2017
What are our treatment options today in the post-ASCT setting in patients with classical HL?
FAQ published on June 7, 2017